Responder status · treatment of disordered and problem gambling
It is very uncertain whether antidepressants changes responder status compared with placebo (very low certainty).
1 finding from 1 review
Gambling symptom severity · treatment of disordered and problem gambling
1 finding from 1 review
Deatha Timing of outcome assessment: 12 months · community‐dwelling adults with a diagnosis of borderline personality disorder
Joint crisis plan plus treatment as usual showed no clear difference in deatha Timing of outcome assessment: 6 months compared with treatment (low certainty).
1 finding from 1 review
Self‐harm Measured by: clinicians Timing of outcome assessment: end of treatment · community‐dwelling adults with a diagnosis of borderline personality disorder
1 finding from 1 review
Suicide‐related outcomes Timing of outcome assessment: end of treatment (6 to 12 weeks treatment duration) · community‐dwelling adults with a diagnosis of borderline personality disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Violence perpetration · community‐dwelling adults with a diagnosis of borderline personality disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hospital admissions: inpatient mental health nights Timing of outcome assessment: 6 months · community‐dwelling adults with a diagnosis of borderline personality disorder
1 finding from 1 review
Quality of life · community‐dwelling adults with a diagnosis of borderline personality disorder
1 finding from 1 review
Cost‐effectiveness · community‐dwelling adults with a diagnosis of borderline personality disorder
1 finding from 1 review
Eradication of MRSA · adults or children with positive microbiological isolate of MRSA from a respiratory tract specimen
Active treatment showed no clear difference in eradication of MRSA: number of participants that were MRSA‐negativea compared with observation only (low certainty).
1 finding from 1 review
Quality of life: CFQ‐R respiratory domain: absolute change from baseline · adults and children with cystic fibrosis and a positive microbiological isolate of MRSA from a respiratory tract specimen
1 finding from 1 review
FEV1 % predicted: absolute change from baseline · adults and children with cystic fibrosis and a positive microbiological isolate of MRSA from a respiratory tract specimen
1 finding from 1 review
Growth · adults and children with cystic fibrosis and a positive microbiological isolate of MRSA from a respiratory tract specimen
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Exacerbation frequency · adults and children with cystic fibrosis and a positive microbiological isolate of MRSA from a respiratory tract specimen
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects of treatment · adults and children with cystic fibrosis and a positive microbiological isolate of MRSA from a respiratory tract specimen
Oral plus nebulised antibiotics showed no clear difference in adverse effects of treatment compared with oral antibiotics plus nebulised placebo (low certainty).
1 finding from 1 review
Time until next positive MRSA isolate (from clinically relevant respiratory culture) · adults or children with positive microbiological isolate of MRSA from a respiratory tract specimen
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life: CFRSD‐CRISS symptom score · adults or children with positive microbiological isolate of MRSA from a respiratory tract specimen
1 finding from 1 review
FEV1 % predicted: absolute change from baseline · adults or children with positive microbiological isolate of MRSA from a respiratory tract specimen
1 finding from 1 review
Change in weight (kg) · adults or children with positive microbiological isolate of MRSA from a respiratory tract specimen
1 finding from 1 review
Exacerbation frequency · adults or children with positive microbiological isolate of MRSA from a respiratory tract specimen
1 finding from 1 review